Shanghai ZJ Bio-Tech Co. Ltd. A (688317) — Working Capital to Net Assets Ratio
Shanghai ZJ Bio-Tech Co. Ltd. A (688317) has a Working Capital to Net Assets ratio of 84.7% as of March 2026. Working capital of CN¥2.80 Billion (current assets of CN¥2.91 Billion minus current liabilities of CN¥115.71 Million) is measured against net assets of CN¥3.30 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Shanghai ZJ Bio-Tech Co. Ltd. A free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Shanghai ZJ Bio-Tech Co. Ltd. A Working Capital to Net Assets (2013–2025)
This chart shows how Shanghai ZJ Bio-Tech Co. Ltd. A's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the ratio stands at 84.7%, reflecting working capital of CN¥2.80 Billion against net assets of CN¥3.30 Billion CNY. See how many days can Shanghai ZJ Bio-Tech Co. Ltd. A fund operations to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Shanghai ZJ Bio-Tech Co. Ltd. A (2013–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Shanghai ZJ Bio-Tech Co. Ltd. A from 2013 to 2025, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market value of Shanghai ZJ Bio-Tech Co. Ltd. A.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 85.4% | CN¥2.86 Billion | CN¥3.35 Billion | CN¥2.99 Billion | CN¥126.58 Million | ▲ +8.7 pp |
| 2024 | 76.7% | CN¥2.79 Billion | CN¥3.64 Billion | CN¥2.94 Billion | CN¥145.99 Million | ▲ +0.1 pp |
| 2023 | 76.6% | CN¥2.93 Billion | CN¥3.82 Billion | CN¥3.17 Billion | CN¥236.56 Million | ▼ -4.0 pp |
| 2022 | 80.6% | CN¥3.39 Billion | CN¥4.20 Billion | CN¥3.91 Billion | CN¥523.86 Million | ▼ -1.5 pp |
| 2021 | 82.1% | CN¥3.14 Billion | CN¥3.83 Billion | CN¥3.55 Billion | CN¥409.00 Million | ▲ +0.3 pp |
| 2020 | 81.9% | CN¥1.20 Billion | CN¥1.46 Billion | CN¥1.58 Billion | CN¥385.39 Million | ▲ +21.2 pp |
| 2019 | 60.6% | CN¥346.70 Million | CN¥571.84 Million | CN¥403.67 Million | CN¥56.97 Million | ▼ -7.5 pp |
| 2018 | 68.1% | CN¥362.91 Million | CN¥532.66 Million | CN¥405.15 Million | CN¥42.24 Million | ▲ +2.9 pp |
| 2017 | 65.3% | CN¥308.50 Million | CN¥472.70 Million | CN¥342.51 Million | CN¥34.00 Million | ▼ -1.2 pp |
| 2016 | 66.5% | CN¥321.56 Million | CN¥483.90 Million | CN¥354.03 Million | CN¥32.46 Million | ▼ -6.5 pp |
| 2015 | 72.9% | CN¥250.53 Million | CN¥343.47 Million | CN¥291.16 Million | CN¥40.63 Million | ▲ +40.1 pp |
| 2014 | 32.8% | CN¥36.20 Million | CN¥110.35 Million | CN¥106.26 Million | CN¥70.06 Million | ▼ -17.0 pp |
| 2013 | 49.8% | CN¥58.76 Million | CN¥118.03 Million | CN¥82.30 Million | CN¥23.53 Million | — |